1. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. (27th November 2018) Authors: McMullin, Mary Frances; Harrison, Claire N.; Ali, Sahra; Cargo, Catherine; Chen, Frederick; Ewing, Joanne; Garg, Mamta; Godfrey, Anna; S, Steven Knapper; McLornan, Donal P.; Nangalia, Jyoti; Sekhar, Mallika; Wadelin, Frances; Mead, Adam J. Journal: British journal of haematology Issue: Volume 184:Number 2(2019) Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline. (13th November 2018) Authors: McMullin, Mary F. F.; Mead, Adam J.; Ali, Sahra; Cargo, Catherine; Chen, Frederick; Ewing, Joanne; Garg, Mamta; Godfrey, Anna; Knapper, Steven; McLornan, Donal P.; Nangalia, Jyoti; Sekhar, Mallika; Wadelin, Frances; Harrison, Claire N. Journal: British journal of haematology Issue: Volume 184:Number 2(2019) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A retrospective real-world study of the current treatment pathways for myelofibrosis in the United Kingdom: the REALISM UK study. (March 2022) Authors: Mead, Adam J.; Butt, Nauman M.; Nagi, Waseem; Whiteway, Alastair; Kirkpatrick, Suriya; Rinaldi, Ciro; Roughley, Catherine; Ackroyd, Sam; Ewing, Joanne; Neelakantan, Pratap; Garg, Mamta; Tucker, David; Murphy, John; Patel, Hitesh; Bains, Rozinder; Chiu, Gavin; Hickey, Joe; Harrison, Claire; Somerv... Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A single dose of eculizumab terminated life‐threatening haemolysis in idiopathic IgM‐mediated warm autoimmune haemolytic anaemia: A case report. (6th January 2022) Authors: Garg, Mamta; Agarwal, Siddharth; Altohami, Mohammed Journal: British journal of haematology Issue: Volume 197:Number 2(2022) Page Start: e28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A United Kingdom Immune Thrombocytopenia (ITP) Forum review of practice: thrombopoietin receptor agonists. (23rd November 2016) Authors: Thachil, Jecko; Bagot, Catherine; Bradbury, Charlotte; Cooper, Nichola; Lester, Will; Grainger, John D.; Lowe, Gillian; Evans, Gillian; Talks, Kate; Sibson, Keith; Garg, Mamta; Murphy, Michael F.; Watson, Henry G.; Bolton‐Maggs, Paula H. B.; Watson, Shirley; Scully, Marie; Provan, Drew; Newland, ... Journal: British journal of haematology Issue: Volume 180:Number 4(2018) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. British Society for Haematology guidelines for the laboratory diagnosis of malaria. (9th March 2022) Authors: Rogers, Claire L.; Bain, Barbara J.; Garg, Mamta; Fernandes, Savio; Mooney, Ciaran; Chiodini, Peter L. Journal: British journal of haematology Issue: Volume 197:Number 3(2022) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of age and frailty on the efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. Issue 6 (3rd May 2021) Authors: Auner, Holger W.; Gavriatopoulou, Maria; Delimpasi, Sosana; Simonova, Maryana; Spicka, Ivan; Pour, Ludek; Dimopoulos, Meletios A.; Kriachok, Iryna; Pylypenko, Halyna; Leleu, Xavier; Doronin, Vadim; Usenko, Ganna; Hajek, Roman; Benjamin, Reuben; Dolai, Tuphan Kanti; Sinha, Dinesh Kumar; Venner, Ch... Journal: American journal of hematology Issue: Volume 96:Issue 6(2021) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Issue 1 (January 2019) Authors: Jackson, Graham H; Davies, Faith E; Pawlyn, Charlotte; Cairns, David A; Striha, Alina; Collett, Corinne; Hockaday, Anna; Jones, John R; Kishore, Bhuvan; Garg, Mamta; Williams, Cathy D; Karunanithi, Kamaraj; Lindsay, Jindriska; Jenner, Matthew W; Cook, Gordon; Russell, Nigel H; Kaiser, Martin F; D... Journal: Lancet oncology Issue: Volume 20:Issue 1(2019) Page Start: 57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MUKtwelve protocol: a phase II randomised, controlled, open, parallel group, multicentre trial of selinexor, cyclophosphamide and prednisolone (SCP) versus cyclophosphamide and prednisolone (CP) in patients with relapsed or refractory multiple myeloma. Issue 10 (26th October 2022) Authors: Kendall, Jessica; Hall, Andrew; Roberts, Sadie; Brown, Sarah; Boyd, Kevin; Auner, Holger W; Garg, Mamta; Kaiser, Martin Journal: BMJ open Issue: Volume 12:Issue 10(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗